Abstract
Summary
The global Cardiovascular Embolic Protection Device market size is projected to grow from US$ 489.1 million in 2022 to US$ 848.9 million in 2029; it is expected to grow at a CAGR of 8.2% from 2023 to 2029.
United States market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cardiovascular Embolic Protection Device players cover InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc., Edwards and Lifesciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Cardiovascular Embolic Protection Device Industry Forecast” looks at past sales and reviews total world Cardiovascular Embolic Protection Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Embolic Protection Device sales for 2023 through 2029. With Cardiovascular Embolic Protection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Embolic Protection Device industry.
This Insight Report provides a comprehensive analysis of the global Cardiovascular Embolic Protection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Embolic Protection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Embolic Protection Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Embolic Protection Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Embolic Protection Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Embolic Protection Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Distal Occlusion Devices
Proximal Occlusion Devices
Distal Filters
Segmentation by application
Hospitals & Clinics
Ambulatoy Surgery Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
InspireMD, Inc.
Boston Scientific Corporation
Abbott Laboratories
Medtronic plc
Cardinal Health
Contego Medical, LLC
Silk Road Medical, Inc.
Edwards
Lifesciences Corporation
Lepu Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiovascular Embolic Protection Device market?
What factors are driving Cardiovascular Embolic Protection Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiovascular Embolic Protection Device market opportunities vary by end market size?
How does Cardiovascular Embolic Protection Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cardiovascular Embolic Protection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cardiovascular Embolic Protection Device players cover InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc., Edwards and Lifesciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Cardiovascular Embolic Protection Device Industry Forecast” looks at past sales and reviews total world Cardiovascular Embolic Protection Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Embolic Protection Device sales for 2023 through 2029. With Cardiovascular Embolic Protection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Embolic Protection Device industry.
This Insight Report provides a comprehensive analysis of the global Cardiovascular Embolic Protection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Embolic Protection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Embolic Protection Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Embolic Protection Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Embolic Protection Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Embolic Protection Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Distal Occlusion Devices
Proximal Occlusion Devices
Distal Filters
Segmentation by application
Hospitals & Clinics
Ambulatoy Surgery Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
InspireMD, Inc.
Boston Scientific Corporation
Abbott Laboratories
Medtronic plc
Cardinal Health
Contego Medical, LLC
Silk Road Medical, Inc.
Edwards
Lifesciences Corporation
Lepu Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cardiovascular Embolic Protection Device market?
What factors are driving Cardiovascular Embolic Protection Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiovascular Embolic Protection Device market opportunities vary by end market size?
How does Cardiovascular Embolic Protection Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Embolic Protection Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cardiovascular Embolic Protection Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cardiovascular Embolic Protection Device by Country/Region, 2018, 2022 & 2029
2.2 Cardiovascular Embolic Protection Device Segment by Type
2.2.1 Distal Occlusion Devices
2.2.2 Proximal Occlusion Devices
2.2.3 Distal Filters
2.3 Cardiovascular Embolic Protection Device Sales by Type
2.3.1 Global Cardiovascular Embolic Protection Device Sales Market Share by Type (2018-2023)
2.3.2 Global Cardiovascular Embolic Protection Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cardiovascular Embolic Protection Device Sale Price by Type (2018-2023)
2.4 Cardiovascular Embolic Protection Device Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Ambulatoy Surgery Centers
2.4.3 Others
2.5 Cardiovascular Embolic Protection Device Sales by Application
2.5.1 Global Cardiovascular Embolic Protection Device Sale Market Share by Application (2018-2023)
2.5.2 Global Cardiovascular Embolic Protection Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cardiovascular Embolic Protection Device Sale Price by Application (2018-2023)
3 Global Cardiovascular Embolic Protection Device by Company
3.1 Global Cardiovascular Embolic Protection Device Breakdown Data by Company
3.1.1 Global Cardiovascular Embolic Protection Device Annual Sales by Company (2018-2023)
3.1.2 Global Cardiovascular Embolic Protection Device Sales Market Share by Company (2018-2023)
3.2 Global Cardiovascular Embolic Protection Device Annual Revenue by Company (2018-2023)
3.2.1 Global Cardiovascular Embolic Protection Device Revenue by Company (2018-2023)
3.2.2 Global Cardiovascular Embolic Protection Device Revenue Market Share by Company (2018-2023)
3.3 Global Cardiovascular Embolic Protection Device Sale Price by Company
3.4 Key Manufacturers Cardiovascular Embolic Protection Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiovascular Embolic Protection Device Product Location Distribution
3.4.2 Players Cardiovascular Embolic Protection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiovascular Embolic Protection Device by Geographic Region
4.1 World Historic Cardiovascular Embolic Protection Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Cardiovascular Embolic Protection Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cardiovascular Embolic Protection Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cardiovascular Embolic Protection Device Market Size by Country/Region (2018-2023)
4.2.1 Global Cardiovascular Embolic Protection Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cardiovascular Embolic Protection Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cardiovascular Embolic Protection Device Sales Growth
4.4 APAC Cardiovascular Embolic Protection Device Sales Growth
4.5 Europe Cardiovascular Embolic Protection Device Sales Growth
4.6 Middle East & Africa Cardiovascular Embolic Protection Device Sales Growth
5 Americas
5.1 Americas Cardiovascular Embolic Protection Device Sales by Country
5.1.1 Americas Cardiovascular Embolic Protection Device Sales by Country (2018-2023)
5.1.2 Americas Cardiovascular Embolic Protection Device Revenue by Country (2018-2023)
5.2 Americas Cardiovascular Embolic Protection Device Sales by Type
5.3 Americas Cardiovascular Embolic Protection Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Embolic Protection Device Sales by Region
6.1.1 APAC Cardiovascular Embolic Protection Device Sales by Region (2018-2023)
6.1.2 APAC Cardiovascular Embolic Protection Device Revenue by Region (2018-2023)
6.2 APAC Cardiovascular Embolic Protection Device Sales by Type
6.3 APAC Cardiovascular Embolic Protection Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiovascular Embolic Protection Device by Country
7.1.1 Europe Cardiovascular Embolic Protection Device Sales by Country (2018-2023)
7.1.2 Europe Cardiovascular Embolic Protection Device Revenue by Country (2018-2023)
7.2 Europe Cardiovascular Embolic Protection Device Sales by Type
7.3 Europe Cardiovascular Embolic Protection Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Embolic Protection Device by Country
8.1.1 Middle East & Africa Cardiovascular Embolic Protection Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cardiovascular Embolic Protection Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Cardiovascular Embolic Protection Device Sales by Type
8.3 Middle East & Africa Cardiovascular Embolic Protection Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiovascular Embolic Protection Device
10.3 Manufacturing Process Analysis of Cardiovascular Embolic Protection Device
10.4 Industry Chain Structure of Cardiovascular Embolic Protection Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiovascular Embolic Protection Device Distributors
11.3 Cardiovascular Embolic Protection Device Customer
12 World Forecast Review for Cardiovascular Embolic Protection Device by Geographic Region
12.1 Global Cardiovascular Embolic Protection Device Market Size Forecast by Region
12.1.1 Global Cardiovascular Embolic Protection Device Forecast by Region (2024-2029)
12.1.2 Global Cardiovascular Embolic Protection Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiovascular Embolic Protection Device Forecast by Type
12.7 Global Cardiovascular Embolic Protection Device Forecast by Application
13 Key Players Analysis
13.1 InspireMD, Inc.
13.1.1 InspireMD, Inc. Company Information
13.1.2 InspireMD, Inc. Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.1.3 InspireMD, Inc. Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 InspireMD, Inc. Main Business Overview
13.1.5 InspireMD, Inc. Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.3.3 Abbott Laboratories Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Medtronic plc
13.4.1 Medtronic plc Company Information
13.4.2 Medtronic plc Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.4.3 Medtronic plc Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medtronic plc Main Business Overview
13.4.5 Medtronic plc Latest Developments
13.5 Cardinal Health
13.5.1 Cardinal Health Company Information
13.5.2 Cardinal Health Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.5.3 Cardinal Health Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cardinal Health Main Business Overview
13.5.5 Cardinal Health Latest Developments
13.6 Contego Medical, LLC
13.6.1 Contego Medical, LLC Company Information
13.6.2 Contego Medical, LLC Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.6.3 Contego Medical, LLC Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Contego Medical, LLC Main Business Overview
13.6.5 Contego Medical, LLC Latest Developments
13.7 Silk Road Medical, Inc.
13.7.1 Silk Road Medical, Inc. Company Information
13.7.2 Silk Road Medical, Inc. Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.7.3 Silk Road Medical, Inc. Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Silk Road Medical, Inc. Main Business Overview
13.7.5 Silk Road Medical, Inc. Latest Developments
13.8 Edwards
13.8.1 Edwards Company Information
13.8.2 Edwards Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.8.3 Edwards Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Edwards Main Business Overview
13.8.5 Edwards Latest Developments
13.9 Lifesciences Corporation
13.9.1 Lifesciences Corporation Company Information
13.9.2 Lifesciences Corporation Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.9.3 Lifesciences Corporation Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lifesciences Corporation Main Business Overview
13.9.5 Lifesciences Corporation Latest Developments
13.10 Lepu Medical Technology
13.10.1 Lepu Medical Technology Company Information
13.10.2 Lepu Medical Technology Cardiovascular Embolic Protection Device Product Portfolios and Specifications
13.10.3 Lepu Medical Technology Cardiovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lepu Medical Technology Main Business Overview
13.10.5 Lepu Medical Technology Latest Developments
14 Research Findings and Conclusion